Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$1.35 - $4.78 $8 - $28
-6 Reduced 54.55%
5 $0
Q4 2022

Jan 31, 2023

BUY
$4.35 - $6.77 $47 - $74
11 New
11 $0
Q2 2022

Aug 01, 2022

SELL
$2.68 - $6.14 $21 - $49
-8 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$5.05 - $7.53 $25 - $37
5 Added 166.67%
8 $0
Q4 2021

Jan 28, 2022

BUY
$5.67 - $10.18 $17 - $30
3 New
3 $0

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.1B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Schubert & CO Portfolio

Follow Schubert & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

News

Stay updated on Schubert & CO with notifications on news.